Advertisement
Advertisement

ABVX

ABVX logo

Abivax SA - ADR

96.25
USD
Sponsored
-1.78
-1.81%
Jun 11, 09:44 UTC -4
Open

Abivax SA - ADR Profile

About

Abivax SA is a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax SA is based in PARIS, FRANCE.

Info & Links

CEO

Marc de Garidel

Headquarters

7 BD HAUSSMANN
PARIS, I0 75009, FRANCE

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.abivax.com

Auditor

PricewaterhouseCoopers

Share holders

--

Employees

69

Abivax SA - ADR Statistics

Valuation Measures

Market Capitalization2

7.68B

Enterprise Value

7.10B

Enterprise Value/EBITDA(ttm)

-25.60

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

19.14

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-146.43%

Return on Invested Capital(ttm)

213.17%

Return on Assets(ttm)

-88.69%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-277.17M

Net Income Available to Common(ttm)

-380.27M

Diluted EPS(ttm)

-5.37

Share Statistics

Beta (5Y Monthly)

1.68

52-Week Change

1123.01%

S&P 500 52-Week Change

20.67%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

78.54M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

47.91%

Balance Sheet

Total Cash(mrq)

608.81M

Total Cash Per Share(mrq)

7.75

Total Debt(mrq)

2.10M

Total Debt/Equity(mrq)

0.41%

Current Ratio(mrq)

8.75%

Quick Ratio(mrq)

8.75%

Book Value Per Share(mrq)

6.56

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.62

Free Cash Flow(ytd)

-182.46M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement